IL143278A0 - Genetic supressor elements against human immunodeficiency virus - Google Patents

Genetic supressor elements against human immunodeficiency virus

Info

Publication number
IL143278A0
IL143278A0 IL14327899A IL14327899A IL143278A0 IL 143278 A0 IL143278 A0 IL 143278A0 IL 14327899 A IL14327899 A IL 14327899A IL 14327899 A IL14327899 A IL 14327899A IL 143278 A0 IL143278 A0 IL 143278A0
Authority
IL
Israel
Prior art keywords
supressor
genetic
immunodeficiency virus
human immunodeficiency
against human
Prior art date
Application number
IL14327899A
Original Assignee
Subsidiary No 3 Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Subsidiary No 3 Inc filed Critical Subsidiary No 3 Inc
Publication of IL143278A0 publication Critical patent/IL143278A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14327899A 1998-12-22 1999-12-17 Genetic supressor elements against human immunodeficiency virus IL143278A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21875598A 1998-12-22 1998-12-22
PCT/US1999/030187 WO2000037635A2 (en) 1998-12-22 1999-12-17 Genetic suppressor elements against human immunodeficiency virus

Publications (1)

Publication Number Publication Date
IL143278A0 true IL143278A0 (en) 2002-04-21

Family

ID=22816389

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14327899A IL143278A0 (en) 1998-12-22 1999-12-17 Genetic supressor elements against human immunodeficiency virus

Country Status (6)

Country Link
EP (1) EP1144621A2 (en)
JP (1) JP2002536964A (en)
AU (1) AU770885B2 (en)
CA (1) CA2355836A1 (en)
IL (1) IL143278A0 (en)
WO (1) WO2000037635A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316210B1 (en) * 1995-12-20 2001-11-13 Subsidiary No. 3, Inc. Genetic suppressor elements against human immunodeficiency virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94482A (en) * 1989-05-25 2003-09-17 Univ Duke Transdominant repressor mutant of retroviral protein, dna encoding the protein and process for their preparation and use thereof
US5217889A (en) * 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements
WO1993012234A1 (en) * 1991-12-13 1993-06-24 Sri International Antiviral reagents based on rna-binding proteins
US6107062A (en) * 1992-07-30 2000-08-22 Inpax, Inc. Antisense viruses and antisense-ribozyme viruses
WO1997007808A1 (en) * 1995-08-25 1997-03-06 The Regents Of The University Of California Chimeric antiviral agents which incorporate rev binding nucleic acids
US5753490A (en) * 1995-11-28 1998-05-19 Clinical Technologies, Inc. Recombinant HIV and modified packaging cells and method for treating acquired immune deficiency syndrome
US6426412B1 (en) * 1995-12-20 2002-07-30 Subsidiary No. 3, Inc. Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements
US6071743A (en) * 1997-06-02 2000-06-06 Subsidiary No. 3, Inc. Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes

Also Published As

Publication number Publication date
WO2000037635A3 (en) 2001-10-18
WO2000037635A2 (en) 2000-06-29
JP2002536964A (en) 2002-11-05
AU2195400A (en) 2000-07-12
CA2355836A1 (en) 2000-06-29
EP1144621A2 (en) 2001-10-17
AU770885B2 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
GB2337755B (en) Virus vaccine
EP1041888A4 (en) Anti-retroviral immunogens, preparation and use
GB9812613D0 (en) Vaccine
GB9904991D0 (en) Genetic screening
GB9826069D0 (en) HIV vaccine
HK1045324A1 (en) Viral variants
GB9929464D0 (en) Complementary peptide ligande generated from the human genome
GB0027072D0 (en) Vaccine
SG60187A1 (en) Transgenic virus
IL143278A0 (en) Genetic supressor elements against human immunodeficiency virus
GB9925432D0 (en) Virus preparation
GB9702990D0 (en) Virus vaccine
DE69940886D1 (en) Hiv impfstoff
GB9811171D0 (en) Viral vector
GB9911599D0 (en) Comb
AU7105500A (en) Genetic suppressor elements against human immunodeficiency virus
GB9912277D0 (en) Replaceable tine point combination
GB9925434D0 (en) Virus Preparation
GB9807805D0 (en) Vaccine
GB9825951D0 (en) Viral therapeutics
GB9825955D0 (en) Viral therapeutics
GB9930881D0 (en) Modified viral glycoproteins
GB2327065B (en) Folding trap
GB9914931D0 (en) Ambidextrous pen-nib sub-assembly
GB9825053D0 (en) Recombinant virus